ArticleOne health (Amsterdam, Netherlands)2025
National action plan on antimicrobial resistance in selected Asia-Pacific low- and middle-income countries: Perspectives of One Health stakeholders.
Article in One health (Amsterdam, Netherlands), 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Antimicrobial stewardship in poultry farms: Farmers' knowledge, awareness, and practices in Sri Lanka from a One Health perspective.One health (Amsterdam, Netherlands) · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Antimicrobial resistance (AMR) is a One Health problem worldwide, with low and middle-income countries (LMICs) identified as hotspots for AMR development. Countries have created National Action Plans on AMR (NAP-AMR) to address the growing problem; however, studies on the progression of NAP-AMR implementation are scarce. This study explores the current status of the implementation and impact of NAP-AMR in selected LMICs in the Asia-Pacific region through a One Health lens. In total, 102 experts from Bhutan, Nepal, Pakistan, Timor-Leste and Papua New Guinea were enrolled as the study population. Their perspectives on the level of implementation of NAP-AMR were collected via an online questionnaire, and an 80 % response rate was obtained. Participants felt that NAP-AMR implementation was more advanced in human health than in animal or environmental health. Stakeholders perceived to be well informed also tended to be engaged more actively in implementing the responsibilities outlined in the NAP-AMR. Nearly all participants believed that their country needed local antimicrobial prescribing guidelines for humans (94 %) and animals (86 %). Unrestricted access to antimicrobials and poor implementation status of surveillance systems across human, animal and environmental sectors were identified as areas where more progress is needed. Participants' beliefs about the current level of training and awareness related to AMR, as well as current AMR and AMU surveillance, was different from the Quadripartite AMR country self-assessment survey. Further studies need to be conducted to explore the barriers to NAP-AMR implementation in this setting. This study highlights the importance of systematic and transparent monitoring and evaluation frameworks across multiple One Health sectors, to assess progress on implementation of action plans and identify gaps for further investment or intervention. The importance of co-designing monitoring and evaluation frameworks with input from diverse AMR stakeholders across One Health domains was also identified as critical to ensuring the relevance of these frameworks and an equitable approach.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.